- The Injective community approved the IIP-619 upgrade with a 99.99% majority, scaling the network’s real-time EVM architecture and doubling token deflation mechanics.
- Pineapple Financial (NYSE: PAPL) has solidified its position as a major stakeholder, acquiring 7% of the total INJ supply in a recent $2 million open-market purchase.
- Analysts have identified a 30-60% upside potential if INJ maintains a 4-hour close above $3.50, targeting the key psychological resistance at $5.50.
The volatile world of cryptocurrency, Injective (INJ) has captured attention with signs of a potential reversal after a prolonged downtrend. A recent analysis from crypto trader Third Eye, shared on X, points to INJ “loading” at a current market price (CMP) of $3.38, positioning it in a robust demand zone following weeks of price bleed.
The accompanying 4-hour chart from TradingView illustrates this setup vividly: a sharp decline from highs near $6.50, stabilizing around $3.00 with horizontal support lines marking key levels at $5.515, $5.000, $4.500, $4.000, $3.500, and $2.920. The price action shows a consolidation phase, with a potential breakout signaled by a 4-hour close above $3.50.
IIP-619 Mainnet Upgrade: Scaling the Real-Time EVM Frontier
This bullish outlook aligns with significant developments in the Injective ecosystem. On February 19, 2026, the community overwhelmingly approved the IIP-619 governance proposal, enabling a mainnet upgrade that enhances real-time EVM architecture, supports next-generation payments, and expands the MultiVM ecosystem.
This news triggered an immediate 13% surge, pushing INJ to $3.60 before a slight pullback to around $3.20. The upgrade is seen as a catalyst for improved interoperability and faster transaction speeds, potentially attracting more DeFi users to the layer-1 blockchain known for its high-performance decentralized exchange infrastructure.
Adding fuel to the fire, Pineapple Financial announced a $2 million open-market purchase of 560,647 INJ tokens at an average of $3.567, bringing their holdings to 7% of the total supply. This move reflects increasing institutional interest in INJ, especially amid a scheduled protocol-level buyback on February 19 aimed at accelerating token deflation. Recent X posts echo this sentiment, with traders noting upside potential and community members hyping the chain’s future.
Deflationary Mechanics: The Impact of Protocol-Level Buybacks
Technically, the analyst sets clear parameters: support between $3.00 and $2.90, invalidation below $2.90, and targets at $4.50, $5.00, and $5.50—implying 30-60% gains if momentum builds. However, INJ has faced headwinds, trading 76% down yearly and testing key supports amid broader market pressures.
RSI at neutral levels and MACD in consolidation suggest room for movement, but a breakdown could target $2.98. As Injective evolves with RWAs and onchain finance innovations, this could mark a turning point. Traders should monitor volume and broader crypto trends, but the confluence of technicals, upgrades, and accumulation paints a compelling case for recovery. With a market cap around $317 million, INJ remains a high-risk, high-reward play in the Web3 space.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. CoinCryptoNewz is not responsible for any losses incurred. Readers should do their own research before making financial decisions.
